Antitumor effect and radiosensitization of cytosine deaminase and thymidine kinase fusion suicide gene on colorectal carcinoma cells

World Journal of Gastroenterology

Volumn 11, Issue 20, 2005, Pages 3051-3055

  Wu, De Hua ^a   Liu, Li ^a   Chen, Long Hua ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

CD TK; Colorectal carcinoma; Radiosensitization; Suicide gene

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ADENOVIRUS VECTOR; CYTOSINE DEAMINASE; FLUCYTOSINE; GANCICLOVIR; PRODRUG; THYMIDINE KINASE; RADIOSENSITIZING AGENT;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BYSTANDER EFFECT; CARCINOMA CELL; CELL SURVIVAL; CLONOGENIC ASSAY; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; EXPRESSION VECTOR; FUSION GENE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; RADIOSENSITIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUICIDE GENE THERAPY; SURVIVAL RATE; VIRAL GENE DELIVERY SYSTEM; ADENOVIRUS; CELL CULTURE; COLORECTAL TUMOR; GENE FUSION; GENE THERAPY; GENETICS; METHODOLOGY;

ADENOVIRIDAE; ARTIFICIAL GENE FUSION; COLORECTAL NEOPLASMS; CYTOSINE DEAMINASE; GENE THERAPY; HUMANS; PRODRUGS; RADIATION-SENSITIZING AGENTS; THYMIDINE KINASE; TUMOR CELLS, CULTURED;

EID: 20344370056     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i20.3051     Document Type: Article

References (29)

1. Budenholzer B. Screening for colorectal cancer. CMAJ 2001; 164: 965-966
2. Ohlsson B, Palsson B. Follow-up after colorectal cancer surgery. Acta Oncol 2003; 42: 816-826
3. Fibison WJ. Gene therapy. Nurs Clin North Am 2000; 35: 757-772
4. Rochlitz CF. Gene therapy of cancer. Swiss Med Wkly 2001; 131: 4-9
5. Hlubinova K, Hlavaty J, Altaner C. Human glioma cells expressing herpes simplex virus thymidine kinase gene treated with acyclovir, ganciclovir and bromovinyldeoxyuridine. Evaluation of their activity in vitro and in nude mice. Neoplasma 2001; 48: 398-406
6. Okabe S, Arai T, Yamashita H, Sugihara K. Adenovirus-mediated prodrug-enzyme therapy for CEA-producing colorectal cancer cells. J Cancer Res Clin Oncol 2003; 129: 367-373
7. Koyama F, Sawada H, Hirao T, Fujii H, Hamada H, Nakano H. Combined suicide gene therapy for human colon cancer cells using adenovirus-mediated transfer of escherichia coli cytosine deaminase gene and Escherichia coli uracil phosphoribosyltransferase gene with 5-fluorocytosine. Cancer Gene Ther 2000; 7: 1015-1022
8. Ireton GC, McDermott G, Black ME, Stoddard BL. The structure of Escherichia coli cytosine deaminase. J Mol Biol 2002; 315: 687-697
9. Pierrefite-Carle V, Baque P, Gavelli A, Mala M, Chazal M, Gugenheim J, Bourgeon A, Milano G, Staccini P, Rossi B. Cytosine deaminase/5-fluorocytosine-based vaccination against liver tumors: evidence of distant bystander effect. J Natl Cancer Inst 1999; 91: 2014-2019
10. Cho HS, Lee HR, Kim MK. Bystander-mediated regression of murine neuroblastoma via retroviral transfer of the HSV-TK gene. J Korean Med Sci 2004; 19: 107-112
11. Uckert W, Kammertons T, Haack K, Qin Z, Gebert J, Schendel DJ, Blankenstein T. Double suicide gene (cytosine deaminase and herpes simplex virus thymidine kinase) but not single gene transfer allows reliable elimination of tumor cells in vivo. Hum Gene Ther 1998; 9: 855-865
12. Rogulski KR, Zhang K, Kolozsvary A, Kim JH, Freytag SO. Pronounced antitumor effects and tumor radiosensitization of double suicide gene therapy. Clin Cancer Res 1997; 3: 2081-2088
13. Moriuchi S, Wolfe D, Tamura M, Yoshimine T, Miura F, Cohen JB, Glorioso JC. Double suicide gene therapy using a replication defective herpes simplex virus vector reveals reciprocal interference in a malignant glioma model. Gene Ther 2002; 9: 584-591
14. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998; 95: 2509-2514
15. Chang JW, Lee H, Kim E, Lee Y, Chung SS, Kim JH. Combined antitumor effects of an adenoviral cytosine deaminase/thymidine kinase fusion gene in rat C6 glioma. Neurosurgery 2000; 47: 931-939
16. Uckert W, Kammertons T, Haack K, Qin Z, Gebert J, Schendel DJ, Blankenstein T. Double suicide gene (cytosine deaminase and herpes simplex virus thymidine kinase) but not single gene transfer allows reliable elimination of tumor cells in vivo. Hum Gene Ther 1998; 9: 855-865
17. Yoshimura I, Suzuki S, Tadakuma T, Hayakawa M. Suicide gene therapy on LNCaP human prostate cancer cells. Int J Urol 2001; 8: S5-8
18. Kieback DG, Fischer DC, Engehausen DG, Sauerbrei W, Oehler MK, Tong XW, Aguilar-Cordova E. Intraperitoneal adenovirus-mediated suicide gene therapy in combination with either topotecan or paclitaxel in nude mice with human ovarian cancer. Cancer Gene Ther 2002; 9: 478-481
19. Aghi M, Kramm CM, Chou TC, Breakefield XO, Chiocca EA. Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies. J Natl Cancer Inst 1998; 90: 370-380
20. Kuriyama S, Mitoro A, Yamazaki M, Tsujinoue H, Nakatani T, Akahane T, Toyokawa Y, Kojima H, Okamoto S, Fukui H. Comparison of gene therapy with the herpes simplex virus thymidine kinase gene and the bacterial cytosine deaminase gene for the treatment of hepatocellular carcinoma. Scand J Gastroenterol 1999; 34: 1033-1041
21. Dong Y, Wen P, Manome Y, Parr M, Hirshowitz A, Chen L, Hirschowitz EA, Crystal R, Weichselbaum R, Kufe DW, Fine HA. In vivo replication-deficient adenovirus vector-mediated transduction of the cytosine deaminase gene sensitizes glioma cells to 5-fluorocytosine. Hum Gene Ther 1996; 7: 713-720
22. Imaizumi K, Hasegawa Y, Kawabe T, Emi N, Saito H, Naruse K, Shimokata K. Bystander tumoricidal effect and gap junctional communication in lung cancer cell lines. Am J Respir Cell Mol Biol 1998; 18: 205-212
23. van Dillen IJ, Mulder NH, Vaalburg W, de Vries EF, Hospers GA. Influence of the bystander effect on HSV-tk/GCV gene therapy. A review. Curr Gene Ther 2002; 2: 307-322
24. Namba H, Tagawa M, Iwadate Y, Kimura M, Sueyoshi K, Sakiyama S. Bystander effect-mediated therapy of experimental brain tumor by genetically engineered tumor cells. Hum Gene Ther 1998; 9: 5-11
25. Lee YJ, Lee H, Borrelli MJ. Gene transfer into human prostate adenocarcinoma cells with an adenoviral vector: Hyperthermia enhances a double suicide gene expression, cytotoxicity and radiotoxicity. Cancer Gene Ther 2002; 9: 267-274
26. Freytag SO, Rogulski KR, Paielli DL, Gilbert JD, Kim JH. A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy. Hum Gene Ther 1998; 9: 1323-1333
27. Scanlon KJ. Cancer gene therapy: challenges and opportunities. Anticancer Res 2004; 24: 501-504
28. Kay MA, Glorioso JC, Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 2001; 7: 33-40
29. Xia X, Brown S, Lu M, Kim JH. Phase I study of replication-competent adenovirus-mediated double-suicide gene therapy in combination with conventional-dose three-dimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate- to high-risk prostate cancer. Cancer Res 2003; 63: 7497-7506